Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application Pharma Vet brings 20+ years of Legal, Compliance, and Commercialization Expertise as Company prepares ADHD Drug Filing GlobeNewswire July 09, 2025 KANSAS CITY, Kan., July 09, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its […]

GSR III Acquisition Corp. and Terra Innovatum Announce MOU for First-of-a-Kind SOLO Deployment Site at Rock City Development’s Industrial Park, with Future Option to Deploy 50 SOLO Reactors On-Site for Commercial Expansion

GSR III Acquisition Corp. and Terra Innovatum Announce MOU for First-of-a-Kind SOLO Deployment Site at Rock City Development's Industrial Park, with Future Option to Deploy 50 SOLO Reactors On-Site for Commercial Expansion GlobeNewswire July 09, 2025 Partnership Agreement Provides Site for First-Of-A-Kind (FOAK) SOLO(TM) Nuclear Micro Modular Reactor (1 MWe) Agreement Includes Option to Purchase

‘Lavender & The Butterfly Nation’ Breaks Ground as World’s First GenAI-Hybrid Animated Feature Blending AI with Human Emotion

'Lavender & The Butterfly Nation' Breaks Ground as World's First GenAI-Hybrid Animated Feature Blending AI with Human Emotion GlobeNewswire July 09, 2025 HOLLYWOOD, July 09, 2025 (GLOBE NEWSWIRE) — IMAGENai Inc., a visionary GenAI creative studio, introduces “Lavender & The Butterfly Nation”, the world's first GenAI-hybrid animated film blending AI-powered animation with human artistry. The

Universitat Politecnica de Catalunya Joins League of Entropy in Collaboration with Randamu to Strengthen Decentralized Randomness

Universitat Politecnica de Catalunya Joins League of Entropy in Collaboration with Randamu to Strengthen Decentralized Randomness GlobeNewswire July 09, 2025 BARCELONA, SPAIN, July 09, 2025 (GLOBE NEWSWIRE) — Randamu, the Web3 infrastructure company behind the drand and dcipher networks today announced that the Universitat Politecnica de Catalunya (UPC), a renowned technical university known for its

TerrAscend Completes $79 Million Non-Dilutive Debt Financing

TerrAscend Completes $79 Million Non-Dilutive Debt Financing GlobeNewswire July 09, 2025 Proceeds used to retire $68 million of existing debt with the remainder designated for future growth initiatives Additional facility of up to $35 million available for strategic M&A No material debt maturing until late 2028 TORONTO, July 09, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp.

RENEW Energy Partners Upgrades Mass General Brigham’s Energy Portfolio to Unlock Capital

RENEW Energy Partners Upgrades Mass General Brigham's Energy Portfolio to Unlock Capital High-efficiency energy system boosts performance by 10%, reducing operating costs at nonprofit hospital GlobeNewswire July 09, 2025 BOSTON, July 09, 2025 (GLOBE NEWSWIRE) — RENEW Energy Partners (RENEW), a leading provider specializing in financing and deploying large-scale energy projects, advances the energy portfolio

Benitec Biopharma Provides Operational Updates

Benitec Biopharma Provides Operational Updates GlobeNewswire July 09, 2025 -In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Board Review Has Been Completed for All Six Subjects Enrolled into Cohort 1, and

FluidForm Bio(TM) Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions

FluidForm Bio(TM) Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions Presentation also given at the 20th World Congress of the International Pancreas & Islet Transplant Association (IPITA) GlobeNewswire July 09, 2025 WALTHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) — FluidForm Bio(TM), a

Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026

Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026 GlobeNewswire July 09, 2025 NORCROSS, Ga., July 09, 2025 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and portal hypertension, announced today

Introducing Aptean Fresh Produce ERP: The Next-Generation of Produce Pro Software

Introducing Aptean Fresh Produce ERP: The Next-Generation of Produce Pro Software GlobeNewswire July 09, 2025 Unifying Decades of Fresh Produce Expertise with Cutting-Edge Technology in a Powerful, Cloud-Based ERP Solution ALPHARETTA, Ga., July 09, 2025 (GLOBE NEWSWIRE) — Aptean, a global leader in mission-critical enterprise software solutions, announces the launch of Aptean Fresh Produce ERP,

Scroll to Top